1.
Fed Regist
; 80(197): 61298-302, 2015 Oct 13.
Artículo
en Inglés
| MEDLINE
| ID: mdl-26470404
RESUMEN
The Food and Drug Administration (FDA) is issuing a final order to reclassify shortwave diathermy (SWD) for all other uses, a preamendments class III device, into class II (special controls), and to rename the device "nonthermal shortwave therapy'' (SWT). FDA is also making a technical correction in the regulation for the carrier frequency for SWD and SWT devices.